{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:29:06Z","timestamp":1791822546034,"version":"4.3.4"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cca.2016.12.014","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T16:01:27Z","timestamp":1482163287000},"page":"131-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Hypertension: The role of biochemistry in the diagnosis and management"],"prefix":"10.1016","volume":"465","author":[{"given":"P.M.","family":"O'Shea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.P.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fitzgibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2016.12.014_bb0005","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2016.12.014_bb0010","article-title":"Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2016.12.014_bb0015","series-title":"A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. World Health Day 2013","author":"WHO, World Health Organization","year":"2013"},{"key":"10.1016\/j.cca.2016.12.014_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","article-title":"Worldwide prevalence of hypertension: a systematic review","volume":"22","author":"Kearney","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.bmb.a070812","article-title":"Hypertension","volume":"27","author":"Evans","year":"1971","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.cca.2016.12.014_bb0030","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/HYPERTENSIONAHA.116.07090","article-title":"Hypertension guidelines: is it time to reappraise blood pressure thresholds and targets?","volume":"67","author":"Touyz","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2016.12.014_bb0035","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2016.12.014_bb0040","series-title":"National High Blood Pressure Education Program","author":"U.S. Department of Health and Human Services NH, Lung, and Blood Institute","year":"2003"},{"key":"10.1016\/j.cca.2016.12.014_bb0045","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J. Hypertens."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2016.12.014_bb0050","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1681\/ASN.2004110963","article-title":"Joint National Committee VII and European Society of Hypertension\/European Society of Cardiology guidelines for evaluating and treating hypertension: a two-way road?","volume":"16","author":"Mancia","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2016.12.014_bb0055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM198506133122405","article-title":"Osler's maneuver and pseudohypertension","volume":"312","author":"Messerli","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0002-9343(99)80079-5","article-title":"Osler's maneuver: absence of usefulness for the detection of pseudohypertension in an elderly population","volume":"98","author":"Belmin","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cjca.2015.02.016","article-title":"The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"31","author":"Daskalopoulou","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.cca.2016.12.014_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MBP.0b013e3280b08317","article-title":"Blood pressure determination by traditionally trained personnel is less reliable and tends to underestimate the severity of moderate to severe hypertension","volume":"12","author":"Roubsanthisuk","year":"2007","journal-title":"Blood Press. Monit."},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2016.12.014_bb0075","first-page":"S22","article-title":"Errors in assessment of blood pressure: sphygmomanometers and blood pressure cuffs","volume":"85","author":"Campbell","year":"1994","journal-title":"Can J Public Health"},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2016.12.014_bb0080","first-page":"S18","article-title":"Errors in assessment of blood pressure: blood pressure measuring technique","volume":"85","author":"Campbell","year":"1994","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.cca.2016.12.014_bb0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jch.12336","article-title":"Policy statement of the world hypertension league on noninvasive blood pressure measurement devices and blood pressure measurement in the clinical or community setting","volume":"16","author":"Campbell","year":"2014","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2016.12.014_bb0090","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/01.hjh.0000467599.09175.0f","article-title":"7b.02: the association between non-steroidal anti-inflammatory drugs and blood pressure control in hypertensive patients and the relation to gender","volume":"33","author":"Ljungman","year":"2015","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0095","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0895-7061(95)00151-E","article-title":"White coat hypertension and white coat effect. Similarities and differences","volume":"8","author":"Verdecchia","year":"1995","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0100","first-page":"899","article-title":"White-coat hypertension","volume":"25","author":"Verdecchia","year":"1995","journal-title":"G. Ital. Cardiol."},{"key":"10.1016\/j.cca.2016.12.014_bb0105","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/01.hjh.0000186832.41125.8a","article-title":"Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care","volume":"23","author":"Mazzaglia","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2011.05.024","article-title":"Drug-induced hypertension: an unappreciated cause of secondary hypertension","volume":"125","author":"Grossman","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11906-012-0274-7","article-title":"Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension","volume":"14","author":"Sudano","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cca.2016.12.014_bb0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199009133231101","article-title":"Cyclosporine-induced sympathetic activation and hypertension after heart transplantation","volume":"323","author":"Scherrer","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.CIR.101.3.329","article-title":"Essential hypertension. Part I: definition and etiology","volume":"101","author":"Carretero","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2016.12.014_bb0130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1053\/j.ajkd.2009.12.022","article-title":"Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone","volume":"55","author":"Bussemaker","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2016.12.014_bb0135","first-page":"707","article-title":"The diagnosis of essential and secondary hypertension in adults","volume":"50","author":"Dosh","year":"2001","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.cca.2016.12.014_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddm126","article-title":"Genetic basis of polygenic hypertension","volume":"16","author":"Deng","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2016.12.014_bb0145","article-title":"Secondary arterial hypertension: when, who, and how to screen?","author":"Rimoldi","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2016.12.014_bb0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cca.2016.12.014_bb0155","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","article-title":"The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients","volume":"12","author":"Anderson","year":"1994","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00392-010-0148-4","article-title":"Unrecognized secondary causes of hypertension in patients with hypertensive urgency\/emergency: prevalence and co-prevalence","volume":"99","author":"Borgel","year":"2010","journal-title":"Clin. Res. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2016.12.014_bb0165","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/01.hjh.0000467594.34724.e0","article-title":"7a.07: limited contribution of obesity to variations in office, ambulatory and aortic blood pressures in a black African community with prevalent obesity and hypertension","volume":"33","author":"Norton","year":"2015","journal-title":"J. Hypertens."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2016.12.014_bb0170","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/01.hjh.0000467605.15859.cf","article-title":"7b.08: high blood pressure and its variation and the use of beta blocking agents and statins decrease quality of life in drug-treated hypertensive patients","volume":"33","author":"Kantola","year":"2015","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0175","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2014measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0180","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0185","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2016.12.014_bb0190","first-page":"S80","article-title":"Treatment of hypertension in adults with diabetes","volume":"26","author":"Arauz-Pacheco","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2016.12.014_bb0195","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.110.162446","article-title":"Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure","volume":"57","author":"Chen","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2016.12.014_bb0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nature02488","article-title":"Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors","volume":"429","author":"He","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.12.014_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ncpneph1015","article-title":"The importance of the intrarenal renin-angiotensin system","volume":"5","author":"Velez","year":"2009","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.cca.2016.12.014_bb0210","first-page":"2526","article-title":"Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney","volume":"118","author":"Toma","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2016.12.014_bb0215","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/ndt\/gfn377","article-title":"Activation of the renal renin-angiotensin system in diabetes\u2014new concepts","volume":"23","author":"Peti-Peterdi","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.12.014_bb0220","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1681\/ASN.2008070740","article-title":"Activation of the succinate receptor GPR91 in macula densa cells causes renin release","volume":"20","author":"Vargas","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2016.12.014_bb0225","first-page":"s373","article-title":"Is it time for renin measurement to be part of the diabetologist's armamentarium?","volume":"185","author":"Griffin","year":"2016","journal-title":"Ir. J. Med. Sci."},{"issue":"39","key":"10.1016\/j.cca.2016.12.014_bb0230","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2016.12.014_bb0235","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jamainternmed.2016.1979","article-title":"Nonfasting for routine lipid testing: from evidence to action","volume":"176","author":"Mora","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Front. Gastrointest."},{"key":"10.1016\/j.cca.2016.12.014_bb0245","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1681\/ASN.2005010063","article-title":"Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?","volume":"16","author":"Johnson","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"160","key":"10.1016\/j.cca.2016.12.014_bb0250","article-title":"Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery","volume":"194","author":"Powers","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2016.12.014_bb0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ecl.2011.02.001","article-title":"Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness","volume":"40","author":"Schwartz","year":"2011","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.cca.2016.12.014_bb0260","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/hrt.2004.035444","article-title":"Management of hypertension before, during, and after pregnancy","volume":"90","author":"James","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cca.2016.12.014_bb0265","doi-asserted-by":"crossref","first-page":"c2207","DOI":"10.1136\/bmj.c2207","article-title":"Management of hypertensive disorders during pregnancy: summary of NICE guidance","volume":"341","author":"Visintin","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2016.12.014_bb0270","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/1471-0528.12803","article-title":"Variation of urinary protein to creatinine ratio during the day in women with suspected pre-eclampsia","volume":"121","author":"Verdonk","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.cca.2016.12.014_bb0275","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.39532.543947.BE","article-title":"Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review","volume":"336","author":"Cote","year":"2008","journal-title":"BMJ"},{"issue":"58","key":"10.1016\/j.cca.2016.12.014_bb0280","first-page":"e51","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2016.12.014_bb0285","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2016.12.014_bb0290","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0295","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","article-title":"Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension","volume":"58","author":"Pedrosa","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2016.12.014_bb0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/sleep\/26.1.15","article-title":"Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea","volume":"26","author":"Fletcher","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.cca.2016.12.014_bb0305","first-page":"138","article-title":"Renal parenchymal disease and hypertension","volume":"15","author":"Preston","year":"1995","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2016.12.014_bb0310","first-page":"1471","article-title":"Diagnosis of secondary hypertension: an age-based approach","volume":"82","author":"Viera","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.cca.2016.12.014_bb0315","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMcp0809200","article-title":"Clinical practice. Renal-artery stenosis","volume":"361","author":"Dworkin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0320","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajh.2010.174","article-title":"Renovascular hypertension and ischemic nephropathy","volume":"23","author":"Textor","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0325","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(94)93002-3","article-title":"Renal artery stenosis and hypertension","volume":"344","author":"Derkx","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2016.12.014_bb0330","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00004872-200205000-00033","article-title":"Renal vein renin measurements accurately identify renovascular hypertension caused by total occlusion of the renal artery","volume":"20","author":"Rossi","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0335","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0030-1248326","article-title":"Aldosterone to renin ratio\u2014a reliable screening tool for primary aldosteronism?","volume":"42","author":"Tomaschitz","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cca.2016.12.014_bb0340","first-page":"jc20154061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1079","key":"10.1016\/j.cca.2016.12.014_bb0345","article-title":"Hypokalemia in the hypertensive patient","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0350","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","article-title":"Incidence of primary aldosteronism uncomplicated \u201cessential\u201d hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria","volume":"205","author":"Fishman","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2016.12.014_bb0355","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/bmj.2.6035.554","article-title":"Prevalence of primary and secondary hypertension: studies in a random population sample","volume":"2","author":"Berglund","year":"1976","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2016.12.014_bb0360","first-page":"549","article-title":"Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975","volume":"52","author":"Tucker","year":"1977","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cca.2016.12.014_bb0365","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","article-title":"Reliability of screening methods for the diagnosis of primary aldosteronism","volume":"67","author":"Streeten","year":"1979","journal-title":"Am. J. Med."},{"issue":"1289","key":"10.1016\/j.cca.2016.12.014_bb0370","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0375","first-page":"187","article-title":"The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977\u20131981","volume":"2","author":"Andersen","year":"1988","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0380","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.1977.03270400035014","article-title":"Diagnosis of secondary forms of hypertension. A comprehensive protocol","volume":"237","author":"Grim","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2016.12.014_bb0385","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1681.1985.tb02641.x","article-title":"Is aldosterone\/renin ratio useful to screen a hypertensive population for primary aldosteronism?","volume":"12","author":"Hamlet","year":"1985","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cca.2016.12.014_bb0390","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cca.2016.12.014_bb0395","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology 1","volume":"85","author":"Fardella","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0400","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0405","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore 1","volume":"85","author":"Loh","year":"2000","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.cca.2016.12.014_bb0410","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2016.12.014_bb0415","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.cca.2016.12.014_bb0425","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2016.12.014_bb0430","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies","volume":"167","author":"Hannemann","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0435","first-page":"157","article-title":"Prevalence of primary aldosteronism in patient's cohorts and in population-based studies - a review of the current literature","volume":"44","author":"Hannemann","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cca.2016.12.014_bb0440","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","author":"Stowasser","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0445","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0450","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00045415-199907000-00012","article-title":"Primary aldosteronism: a common and curable form of hypertension","volume":"7","author":"Young","year":"1999","journal-title":"Cardiol. Rev."},{"issue":"40","key":"10.1016\/j.cca.2016.12.014_bb0455","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2016.12.014_bb0460","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11906-001-0045-3","article-title":"Primary aldosteronism: rare bird or common cause of secondary hypertension?","volume":"3","author":"Stowasser","year":"2001","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cca.2016.12.014_bb0465","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2016.12.014_bb0470","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1440-1681.2001.03523.x","article-title":"New perspectives on the role of aldosterone excess in cardiovascular disease","volume":"28","author":"Stowasser","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cca.2016.12.014_bb0475","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11906-009-0076-8","article-title":"Aldosterone and cardiovascular risk","volume":"11","author":"Vogt","year":"2009","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cca.2016.12.014_bb0480","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0030-1253417","article-title":"Progress in primary aldosteronism","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cca.2016.12.014_bb0485","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2016.12.014_bb0490","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1445-5994.1976.tb03306.x","article-title":"Outpatient screening tests for primary aldosteronism","volume":"6","author":"Dunn","year":"1976","journal-title":"Aust. NZ J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0500","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0505","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0510","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.2004-1149","article-title":"The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling","volume":"90","author":"Tiu","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0515","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12020-012-9609-z","article-title":"Effect of age on aldosterone\/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups","volume":"42","author":"Yin","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2016.12.014_bb0520","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0525","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis","volume":"48","author":"Rehan","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0530","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0535","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/HJH.0000000000000775","article-title":"A cross-sectional study of the effects of beta-blocker therapy on the interpretation of the aldosterone\/renin ratio: can dosing regimen predict effect?","volume":"34","author":"Griffin","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0540","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cen.12882","article-title":"Beta-blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension","volume":"84","author":"Browne","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2016.02.003","article-title":"French SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 2: first diagnostic steps","author":"Douillard","year":"2016","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0550","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0555","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0560","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.plabm.2016.11.002","article-title":"Screening for primary aldosteronism using the newly developed IDS-iSYS\u00ae automated assay system","volume":"7","author":"O'Shea","year":"2017","journal-title":"Prac. Lab. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0565","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0570","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cca.2014.03.015","article-title":"Combination of LC-MS\/MS aldosterone and automated direct renin in screening for primary aldosteronism","volume":"433","author":"Juutilainen","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.12.014_bb0575","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1373\/clinchem.2006.073460","article-title":"Aldosterone assays: an urgent need for improvement","volume":"52","author":"Stowasser","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0580","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem-30-5-682","article-title":"A radioimmunoassay for plasma aldosterone","volume":"30","author":"Mayes","year":"1970","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0585","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/clinchem\/37.10.1811","article-title":"Plasma renin activity and plasma prorenin assays","volume":"37","author":"Sealey","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0590","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2016.12.014_bb0595","doi-asserted-by":"crossref","DOI":"10.1177\/0004563216645364","article-title":"2016 Endocrine Society guidelines update for the diagnosis of primary aldosteronism: are the proposed aldosterone-to-renin ratio cut-off values relevant in the era of fully automated immunoassays?","author":"Denimal","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0600","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/000456328101800111","article-title":"Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone","volume":"18","author":"Jones","year":"1981","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0605","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps","volume":"52","author":"Schirpenbach","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0610","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","article-title":"Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays","volume":"50","author":"Perschel","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0615","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2015.01.028","article-title":"State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the cardiovascular biomarkers study group of the Italian section of European Society of Ligand Assay (ELAS) and Societa Italiana di Biochimica Clinica (SIBIOC)","volume":"444","author":"Fortunato","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.12.014_bb0620","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry","volume":"55","author":"Taylor","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0625","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.beem.2013.05.015","article-title":"Novel liquid chromatography tandem mass spectrometry (LC-MS\/MS) methods for measuring steroids","volume":"27","author":"Keevil","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0630","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/jclinpath-2012-200990","article-title":"Supported liquid extraction offers improved sample preparation for aldosterone analysis by liquid chromatography tandem mass spectrometry","volume":"65","author":"Van Der Gugten","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2016.12.014_bb0635","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jclinpath-2011-200564","article-title":"Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system","volume":"65","author":"Van Der Gugten","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2016.12.014_bb0640","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0001-2998(75)80033-X","article-title":"Radioimmunoassay of plasma renin activity","volume":"5","author":"Sealey","year":"1975","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0645","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/43.4.694","article-title":"More on renin","volume":"43","author":"Derkx","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0650","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-2944(76)90019-3","article-title":"Influence of angiotensinase ihhibitors on the enzymatic activity of renin","volume":"16","author":"Barrett","year":"1976","journal-title":"Biochem. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0655","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.cca.2016.12.014_bb0660","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/clinchem\/42.7.1051","article-title":"Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity","volume":"42","author":"Derkx","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0665","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/clinchem\/38.10.1959","article-title":"Two-site direct immunoassay specific for active renin","volume":"38","author":"Simon","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0670","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1373\/clinchem.2004.032052","article-title":"Validation of a new automated renin assay","volume":"50","author":"de Bruin","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0675","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/0004563215603401","article-title":"Establishment of reference intervals for aldosterone and renin in a Caucasian population using the newly developed immunodiagnostic systems specialty immunoassay automated system","volume":"53","author":"O'Shea","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0680","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0685","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/clinchem\/46.9.1442a","article-title":"Sample requirements for plasma renin activity and immunoreactive renin","volume":"46","author":"Ulmer","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0690","first-page":"775","article-title":"Comparative study of active and inactive plasma renin in healthy infants and adults","volume":"21","author":"Van Acker","year":"1983","journal-title":"J. Clin. Chem. Clin. Biochem."},{"issue":"Pt 3","key":"10.1016\/j.cca.2016.12.014_bb0695","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1258\/0004563001899401","article-title":"Aldosterone and renin measurements","volume":"37","author":"Cartledge","year":"2000","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0700","first-page":"1383","article-title":"Immunoradiometric assay of active renin in human plasma: comparison with plasma renin activity","volume":"9","author":"Dessi-Fulgheri","year":"1987","journal-title":"Clin. Exp. Hypertens. A"},{"key":"10.1016\/j.cca.2016.12.014_bb0705","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/clinchem\/42.7.993","article-title":"Renin and prorenin: advances and declines in methodology","volume":"42","author":"Sealey","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0710","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004872-199501000-00005","article-title":"Plasma renin methodology: inadequate sensitivity and accuracy of direct renin assay for clinical applications compared with the traditional enzymatic plasma renin activity assay","volume":"13","author":"Sealey","year":"1995","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0715","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0720","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1020798430884","article-title":"Degli Uberti EC. Pathogenesis and prevalence of hypertension in acromegaly","volume":"4","author":"Bondanelli","year":"2001","journal-title":"Pituitary"},{"key":"10.1016\/j.cca.2016.12.014_bb0725","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0730","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2016.12.014_bb0735","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/jcem-71-2-452","article-title":"Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man","volume":"71","author":"Veldhuis","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0740","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1210\/jcem-71-6-1616","article-title":"Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and\/or frequency modulation of underlying pituitary secretory bursts","volume":"71","author":"Veldhuis","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0745","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2005-837667","article-title":"Salivary cortisol measurement\u2014a reliable method for the diagnosis of Cushing's syndrome","volume":"113","author":"Trilck","year":"2005","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.cca.2016.12.014_bb0750","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1210\/jc.2004-2264","article-title":"Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test","volume":"90","author":"Viardot","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0755","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1210\/jc.2003-031790","article-title":"Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes","volume":"89","author":"Yaneva","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0760","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1210\/jc.2008-0139","article-title":"Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses","volume":"93","author":"Elamin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0765","first-page":"764","article-title":"Corticosteroid-binding globulin modulates cortisol concentration responses to a given production rate","volume":"80","author":"Bright","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0770","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1524-6175.2006.05180.x","article-title":"Hyperthyroidism: a secondary cause of isolated systolic hypertension","volume":"8","author":"Prisant","year":"2006","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cca.2016.12.014_bb0775","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1067\/mhj.2002.120766","article-title":"Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism","volume":"143","author":"Dernellis","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2016.12.014_bb0780","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.jhh.1001907","article-title":"Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism","volume":"19","author":"Letizia","year":"2005","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0785","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/10641960903254471","article-title":"Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism","volume":"32","author":"Feldstein","year":"2010","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0790","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/974647","article-title":"Hypertension secondary to PHPT: cause or coincidence?","volume":"2011","author":"Schiffl","year":"2011","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0795","first-page":"77","article-title":"Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems","volume":"21","author":"Gennari","year":"1995","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0800","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000174161","article-title":"Noradrenergic blood pressure dysregulation and cytosolic calcium in primary hyperparathyroidism","volume":"20","author":"Schiffl","year":"1997","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.cca.2016.12.014_bb0805","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2016.12.014_bb0810","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1530\/EC-13-0009","article-title":"Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma","volume":"2","author":"Crona","year":"2013","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.cca.2016.12.014_bb0815","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1051\/medsci\/2012286016","article-title":"Genetics of paragangliomas and pheochromocytomas","volume":"28","author":"Favier","year":"2012","journal-title":"Med. Sci. (Paris)"},{"key":"10.1016\/j.cca.2016.12.014_bb0820","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-11-0497","article-title":"The genetics of phaeochromocytoma: using clinical features to guide genetic testing","volume":"166","author":"Jafri","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0825","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0830","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0835","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11906-010-0151-1","article-title":"Genetic testing for pheochromocytoma","volume":"12","author":"Karasek","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cca.2016.12.014_bb0840","first-page":"jc20134536","article-title":"Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation","author":"Casey","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0845","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors","volume":"83","author":"Eisenhofer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0850","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2002.tb04410.x","article-title":"New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines","volume":"970","author":"Lenders","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2016.12.014_bb0855","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2016.12.014_bb0860","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1258\/acb.2007.007116","article-title":"Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence?","volume":"45","author":"Peaston","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0865","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cca.2016.12.014_bb0870","first-page":"5","article-title":"LC-MS\/MS in the clinical laboratory - where to from here?","volume":"32","author":"Grebe","year":"2011","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.cca.2016.12.014_bb0875","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1196\/annals.1296.072","article-title":"Development of enantioselective immunoassays for free plasma metanephrines","volume":"1018","author":"Manz","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2016.12.014_bb0880","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cca.2010.01.012","article-title":"Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma","volume":"411","author":"Peaston","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.12.014_bb0885","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/cclm.2011.742","article-title":"Enzyme-linked immunoassay for plasma-free metanephrines in the biochemical diagnosis of phaeochromocytoma in adults is not ideal","volume":"50","author":"Mullins","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0890","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1515\/CCLM.2009.162","article-title":"Proficiency test of plasma free and total metanephrines: report from a study group","volume":"47","author":"Pillai","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0895","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1258\/acb.2009.009153","article-title":"Pilot quality assurance programme for plasma metanephrines","volume":"47","author":"Pillai","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0900","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1373\/clinchem.2006.076489","article-title":"Is supine rest necessary before blood sampling for plasma metanephrines?","volume":"53","author":"Lenders","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0905","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/archinte.160.19.2957","article-title":"Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma","volume":"160","author":"Raber","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0910","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000074659","article-title":"Biochemical diagnosis of pheochromocytoma","volume":"31","author":"Eisenhofer","year":"2004","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.cca.2016.12.014_bb0915","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions","volume":"80","author":"Darr","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0920","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2265.2009.03761.x","article-title":"Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasma","volume":"73","author":"Deutschbein","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0925","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.plabm.2016.05.001","article-title":"Evaluating the optimum rest period prior to blood collection for fractionated plasma free metanephrines (PMets) analysis","volume":"5","author":"Griffin","year":"2016","journal-title":"Practical Laboratory Medicine"},{"key":"10.1016\/j.cca.2016.12.014_bb0930","first-page":"3009","article-title":"Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines","volume":"80","author":"Eisenhofer","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2016.12.014_bb0935","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0026-0495(80)90078-5","article-title":"Enhanced plasma norepinephrine response to upright posture and oral glucose administration in elderly human subjects","volume":"29","author":"Young","year":"1980","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2016.12.014_bb0940","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cen.12587","article-title":"Supine or sitting? Economic considerations regarding patient position during plasma metanephrine analysis for the exclusion of chromaffin tumours","volume":"82","author":"Chortis","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0945","article-title":"Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted\/seated patients","author":"Casey","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb0950","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","article-title":"Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines","volume":"51","author":"Eisenhofer","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.12.014_bb0955","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/cen.12602","article-title":"Supine or sitting? Economic and other considerations for use of plasma metanephrines for diagnosis of phaeochromocytoma","volume":"82","author":"Eisenhofer","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0960","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/EJE-13-0673","article-title":"Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma","volume":"170","author":"Pamporaki","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0965","first-page":"281","article-title":"Circannual rhythms of laboratory parameters in serum of elderly subjects. Evaluation by cosinor analysis","volume":"24","author":"Nicolau","year":"1986","journal-title":"Endocrinologie"},{"key":"10.1016\/j.cca.2016.12.014_bb0970","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ajh\/3.5.405","article-title":"Hemodynamics of seasonal adaptation","volume":"3","author":"Izzo","year":"1990","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2016.12.014_bb0975","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-14-0121","article-title":"Seasonal variations of plasma normetanephrine levels in Los Angeles","volume":"170","author":"Yu","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0980","doi-asserted-by":"crossref","first-page":"L3","DOI":"10.1530\/EJE-14-0142","article-title":"Seasonal variations of plasma normetaneprine levels: the authors reply","volume":"170","author":"Pamporaki","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2016.12.014_bb0985","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2015-1256","article-title":"Seasonal variations in plasma free metanephrine concentrations are not evident in the West of Ireland","author":"Griffin","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2016.12.014_bb0990","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","author":"Yu","year":"2010","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.cca.2016.12.014_bb0995","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1258\/acb.2010.010131","article-title":"An audit of management of patients with borderline increased plasma-free metanephrines","volume":"47","author":"Anas","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2016.12.014_bb1000","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/ijcp.12612","article-title":"A review of the management of positive biochemical screening for phaeochromocytoma and paraganglioma: a salutary tale","volume":"69","author":"Garrahy","year":"2015","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.cca.2016.12.014_bb2000","series-title":"The renin-angiotensin-aldosterone system (RAAS)","author":"Rad","year":"2006"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116305083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116305083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T04:56:27Z","timestamp":1718945787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898116305083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":200,"alternative-id":["S0009898116305083"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2016.12.014","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension: The role of biochemistry in the diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}